ClinicalTrials.Veeva

Menu

Multi-organ Transit Time Acquisition Using Contrast Ultrasound

Vanderbilt University Medical Center logo

Vanderbilt University Medical Center

Status

Completed

Conditions

Healthy

Treatments

Drug: Definity Suspension for Injection

Study type

Observational

Funder types

Other

Identifiers

NCT05135169
IRB 212087

Details and patient eligibility

About

Echocardiographic contrast will be administered to volunteers for the purpose of measuring transit time through various organs/vascular beds

Enrollment

16 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • at least 18 years old
  • able to give informed consent

Exclusion criteria

  1. Known allergic reaction to Definity ultrasound contrast
  2. Pregnancy/Nursing - as assessed/disclosed by the participant

Trial design

16 participants in 1 patient group

Contrast administration
Treatment:
Drug: Definity Suspension for Injection

Trial contacts and locations

1

Loading...

Central trial contact

Ken Monahan, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems